Fieldpoint Private Securities’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$17K Sell
105
-174
-62% -$27.5K ﹤0.01% 637
2022
Q1
$52K Buy
279
+6
+2% +$1.14K 0.01% 585
2021
Q4
$72K Buy
273
+13
+5% +$3.5K 0.01% 507
2021
Q3
$75K Buy
260
+70
+37% +$18K 0.02% 477
2021
Q2
$48K Hold
190
0.01% 591
2021
Q1
$37K Buy
190
+5
+3% +$1.02K 0.01% 637
2020
Q4
$35K Buy
+185
New +$33.7K 0.01% 549

Other funds holding RGEN

Fieldpoint Private Securities's RGEN Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Repligen (RGEN) stake by 62% in Q2 2022, selling an estimated $27.5K and leaving 105 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #637.

Fieldpoint Private Securities first reported a position in RGEN in Q4 2020 and has held it in 7 quarters since. The position peaked at $75K in Q3 2021. 405 funds tracked by Wall St. Rank hold RGEN as of Q2 2022.

  • Fieldpoint Private Securities held 105 shares of Repligen worth $17K as of Q2 2022.
  • Fieldpoint Private Securities sold 174 Repligen shares in Q2 2022, an estimated $27.5K.
  • Repligen made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #637 holding.
  • Fieldpoint Private Securities first reported a position in Repligen in Q4 2020 and has held it in 7 quarters since.
  • Fieldpoint Private Securities's Repligen position peaked at $75K in Q3 2021.
  • 405 funds tracked by Wall St. Rank held Repligen as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.